Your browser doesn't support javascript.
loading
Safety of extended interval dosing immune checkpoint inhibitors: a multicenter cohort study.
Cantini, Luca; Paoloni, Francesco; Pecci, Federica; Spagnolo, Francesco; Genova, Carlo; Tanda, Enrica Teresa; Aerts, Sophie; Rebuzzi, Sara Elena; Fornarini, Giuseppe; Zoratto, Federica; Fancelli, Sara; Lupi, Alessio; Della Corte, Carminia Maria; Parisi, Alessandro; Bennati, Chiara; Ortega, Cinzia; Atzori, Francesco; Piovano, Pier Luigi; Orciuolo, Corrado; De Tursi, Michele; Ghidini, Michele; Botticelli, Andrea; Scagnoli, Simone; Belluomini, Lorenzo; Leporati, Rita; Veccia, Antonello; Di Giacomo, Anna Maria; Festino, Lucia; Cortinovis, Diego; Acquati, Mirko; Filetti, Marco; Giusti, Raffaele; Tucci, Marco; Sergi, Maria Chiara; Garutti, Mattia; Puglisi, Fabio; Manglaviti, Sara; Citarella, Fabrizio; Santoni, Matteo; Rijavec, Erika; Lo Russo, Giuseppe; Santini, Daniele; Addeo, Alfredo; Antonuzzo, Lorenzo; Indini, Alice; Rocchi, Marco Bruno Luigi; Cortellini, Alessio; Grossi, Francesco; Ascierto, Paolo Antonio; Aerts, Joachim G J V.
Affiliation
  • Cantini L; Clinical Oncology, Università Politecnica delle Marche, Azienda Ospedaliero-Universitaria delle Marche, Ancona, Italy.
  • Paoloni F; Department of Pulmonary Medicine, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands.
  • Pecci F; Labcorp Drug Development Inc, Princeton, NJ, USA.
  • Spagnolo F; Clinical Oncology, Università Politecnica delle Marche, Azienda Ospedaliero-Universitaria delle Marche, Ancona, Italy.
  • Genova C; Clinical Oncology, Università Politecnica delle Marche, Azienda Ospedaliero-Universitaria delle Marche, Ancona, Italy.
  • Tanda ET; Medical Oncology Unit 2, Istituto di ricovero e cura a carattere scientific (IRCCS) Ospedale Policlinico San Martino, Genova, Italy.
  • Aerts S; Academic Medical Oncology Unit, Istituto di ricovero e cura a carattere scientific (IRCCS) Ospedale Policlinico San Martino, Genoa, Italy.
  • Rebuzzi SE; Department of Internal Medicine and Medical Specialties, School of Medicine, University of Genoa, Italy.
  • Fornarini G; Medical Oncology Unit 2, Istituto di ricovero e cura a carattere scientific (IRCCS) Ospedale Policlinico San Martino, Genova, Italy.
  • Zoratto F; Department of Pulmonary Medicine, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands.
  • Fancelli S; Department of Internal Medicine and Medical Specialties, School of Medicine, University of Genoa, Italy.
  • Lupi A; Medical Oncology Unit, Ospedale San Paolo, Savona, Italy.
  • Della Corte CM; Medical Oncology Unit 1, Istituto di ricovero e cura a carattere scientific (IRCCS) Ospedale Policlinico San Martino, Genoa, Italy.
  • Parisi A; UOC Oncologia, Ospedale Santa Maria Goretti, Latina, Italy.
  • Bennati C; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Ortega C; Clinical Oncology Unit, Careggi University Hospital, Florence, Italy.
  • Atzori F; Clinical Oncology, Università Politecnica delle Marche, Azienda Ospedaliero-Universitaria delle Marche, Ancona, Italy.
  • Piovano PL; Department of Precision Medicine, University of Campania, Italy.
  • Orciuolo C; Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.
  • De Tursi M; S Maria delle Croci Hospital, AUSL della Romagna, Ravenna, Italy.
  • Ghidini M; Oncology, Asl Cn2, Ospedale Michele e Pietro Ferrero, Verduno, Italy.
  • Botticelli A; Medical Oncology Unit, University Hospital and University of Cagliari, Cagliari, Italy.
  • Scagnoli S; Oncology Unit, Azienda Ospedaliera "SS. Antonio e Biagio e C. Arrigo", Alessandria, Italy.
  • Belluomini L; Istituto di ricovero e cura a carattere scientific (IRCCS), National Cancer Institute Regina Elena, Rome, Italy.
  • Leporati R; Department of Innovative Technologies in Medicine and Dentistry, University G. D'Annunzio, Chieti-Pescara, Italy.
  • Veccia A; Oncology Unit, Fondazione Istituto di ricovero e cura a carattere scientific (IRCCS) Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.
  • Di Giacomo AM; Medical Oncology Unit A, Policlinico Umberto I, Radiological, Oncological, Pathological Sciences Department, Sapienza University of Rome, Italy.
  • Festino L; Medical Oncology Unit B, Policlinico Umberto I, Rome, Italy.
  • Cortinovis D; Section of Oncology, Department of Medicine, University of Verona School of Medicine and Verona University Hospital Trust, Verona, Italy.
  • Acquati M; Medical Oncology, Fondazione Istituto di ricovero e cura a carattere scientific (IRCCS) Istituto Nazionale dei Tumori, Milano, Italy.
  • Filetti M; Medical Oncology, Santa Chiara Hospital, Largo Medaglie d'Oro 1, Trento, Italy.
  • Giusti R; Center for Immuno-Oncology, University of Siena, University Hospital of Siena, Siena, Italy.
  • Tucci M; Melanoma Unit, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori Istituto di ricovero e cura a carattere scientific (IRCCS) Fondazione "G. Pascale", Naples, Italy.
  • Sergi MC; SC Oncologia Medica ASST H S Gerardo, Monza, Italy.
  • Garutti M; SC Oncologia Medica ASST H S Gerardo, Monza, Italy.
  • Puglisi F; Phase 1 Unit, Fondazione Policlinico Universitario Agostino Gemelli, Istituto di ricovero e cura a carattere scientific (IRCCS), Rome, Italy.
  • Manglaviti S; Medical Oncology Unit, Sant'Andrea Hospital of Rome, Italy.
  • Citarella F; Medical Oncology Unit, Department of Interdisciplinary Medicine, University of Bari Aldo Moro, Italy.
  • Santoni M; Medical Oncology Unit, Department of Interdisciplinary Medicine, University of Bari Aldo Moro, Italy.
  • Rijavec E; CRO Aviano, National Cancer Institute, Istituto di ricovero e cura a carattere scientific (IRCCS), Aviano, Italy.
  • Lo Russo G; CRO Aviano, National Cancer Institute, Istituto di ricovero e cura a carattere scientific (IRCCS), Aviano, Italy.
  • Santini D; Department of Medicine (DAME), University of Udine, Udine, Italy.
  • Addeo A; Thoracic Unit, Medical Oncology Department 1, Fondazione Istituto di ricovero e cura a carattere scientific (IRCCS) Istituto Nazionale dei Tumori di Milano, Italy.
  • Antonuzzo L; Department of Medical Oncology, Campus Bio-Medico University, Rome, Italy.
  • Indini A; Oncology Unit, Macerata Hospital, Macerata, Italy.
  • Rocchi MBL; Medical Oncology Unit, Ospedale di Circolo e Fondazione Macchi, asst Settelaghi, Varese, Italy.
  • Cortellini A; Thoracic Unit, Medical Oncology Department 1, Fondazione Istituto di ricovero e cura a carattere scientific (IRCCS) Istituto Nazionale dei Tumori di Milano, Italy.
  • Grossi F; UOC Oncologia Medica Territoriale, Sapienza Università, Polo Pontino, Rome, Italy.
  • Ascierto PA; Oncology Department, University Hospital Geneva, Geneva, Switzerland.
  • Aerts JGJV; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
J Natl Cancer Inst ; 115(7): 796-804, 2023 07 06.
Article in En | MEDLINE | ID: mdl-37042716
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Agents, Immunological / Neoplasms Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Natl Cancer Inst Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Agents, Immunological / Neoplasms Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Natl Cancer Inst Year: 2023 Document type: Article Affiliation country: Country of publication: